Towards an integrated blood pressure self-monitoring solution for stroke/TIA in Ireland: a mixed methods feasibility study for the TASMIN5S IRL randomised controlled trial
Background Optimising blood pressure (BP) control is one of the most important modifable risk factors in preventing subsequent stroke where the risk increases by one-third for every 10 mmHg rise in systolic BP. This study evaluated the feasibility and potential efectiveness of blood pressure self-monitoring with planned medication titration, to inform a defnitive trial of the intervention, in patients with a previous stroke or transient ischaemic attack (TIA).
Methods Patients with a history of stroke/TIA and sub-optimal BP control were invited to take part in a mixed methods feasibility study for a randomised controlled trial. Those meeting the inclusion criteria with systolic BP >130 mmHg were randomised to a self-monitoring intervention group or usual care group. The intervention involved self-monitoring BP twice a day for 3 days within a 7-day period, every month, following text message reminders. Treatment escalation, based on a pre-agreed plan by the general practitioner (GP) and patient, was initiated according to the results of these readings. Semi-structured interviews were carried out with patients and clinicians and analysed thematically.
Results Of those identifed, 47% (32/68) attended for assessment. Of those assessed, 15 were eligible for recruitment and were consented and randomised to the intervention or control group on a 2:1 basis. Of those randomised, 93% (14/15) completed the study and there were no adverse events. Systolic BP was lower in the intervention group at 3 months. Participants found the intervention acceptable and easy to use. GPs found it easy to incorporate into their practice activity without increasing workload.
Conclusions TASMIN5S, an integrated blood pressure self-monitoring intervention in patients with a previous stroke/TIA, is feasible and safe to deliver in primary care. A pre-agreed three-step medication titration plan was easily implemented, increased patient involvement in their care, and had no adverse efects. This feasibility study provides important information to inform a defnitive trial to determine the potential efectiveness of the intervention in patients post-stroke or TIA.
PublicationPilot and Feasibility Studies, 2023
Other Funding informationThe intervention development and UK trial were supported by the Stroke Association, UK. The Irish trial was supported by the Health Research Board in Ireland. RD has received an Education and Health Science (Ireland) scholarship.
Sustainable development goals
- (3) Good Health and Well-being
Department or School
- School of Medicine